Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

313 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
FIGO staging of endometrial cancer: 2023.
Berek JS, Matias-Guiu X, Creutzberg C, Fotopoulou C, Gaffney D, Kehoe S, Lindemann K, Mutch D, Concin N; Endometrial Cancer Staging Subcommittee, FIGO Women's Cancer Committee. Berek JS, et al. Among authors: kehoe s. Int J Gynaecol Obstet. 2023 Aug;162(2):383-394. doi: 10.1002/ijgo.14923. Epub 2023 Jun 20. Int J Gynaecol Obstet. 2023. PMID: 37337978 Free article.
Response: FIGO staging of endometrial cancer 2023.
Concin N, Matias-Guiu X, Fotopoulou C, Creutzberg C, Mutch D, Gaffney D, Lindemann K, Kehoe S, Berek JS; FIGO Committee on Women's Cancer. Concin N, et al. Among authors: kehoe s. Int J Gynaecol Obstet. 2024 Jan;164(1):369-372. doi: 10.1002/ijgo.15277. Epub 2023 Dec 6. Int J Gynaecol Obstet. 2024. PMID: 38055215 No abstract available.
Contraceptive strategies for reducing the risk of reproductive cancers.
Aliabadi AR, Wilailak S, McNally O, Berek JS, Sridhar A; FIGO Committee on Contraception; FIGO Committee on Women's Cancer. Aliabadi AR, et al. Int J Gynaecol Obstet. 2024 May 9. doi: 10.1002/ijgo.15567. Online ahead of print. Int J Gynaecol Obstet. 2024. PMID: 38725288 Review.
Investigating harms of testing for ovarian cancer - psychological outcomes and cancer conversion rates in women with symptoms of ovarian cancer: A cohort study embedded in the multicentre ROCkeTS prospective diagnostic study.
Kwong FL, Kristunas C, Davenport C, Aggarwal R, Deeks J, Mallett S, Kehoe S, Timmerman D, Bourne T, Stobart H, Neal R, Menon U, Gentry-Maharaj A, Sturdy L, Ottridge R, Sundar S; ROCkeTS collaborators. Kwong FL, et al. Among authors: kehoe s. BJOG. 2024 Mar 31. doi: 10.1111/1471-0528.17813. Online ahead of print. BJOG. 2024. PMID: 38556698
The Prognostic Characteristics and Recurrence Patterns of High Grade Endometrioid Endometrial Cancer: A Large Retrospective Analysis of a Tertiary Center.
Zouridis A, Zarrindej K, Rencher J, Pappa C, Kashif A, Smyth SL, Sadeghi N, Sattar A, Damato S, Ferrari F, Laganà AS, Abdalla M, Kehoe S, Addley S, Soleymani Majd H. Zouridis A, et al. Among authors: kehoe s. J Clin Med. 2023 Apr 26;12(9):3141. doi: 10.3390/jcm12093141. J Clin Med. 2023. PMID: 37176582 Free PMC article.
The clinicopathological characteristics and survival outcomes of primary expansile vs. infiltrative mucinous ovarian adenocarcinoma: a retrospective study sharing the experience of a tertiary centre.
Nistor S, El-Tawab S, Wong F, Zouridis A, Roux R, Manek S, Gaitskell K, Ahmed AA, Kehoe S, Soleymani Majd H. Nistor S, et al. Among authors: kehoe s. Transl Cancer Res. 2023 Oct 31;12(10):2682-2692. doi: 10.21037/tcr-23-863. Epub 2023 Oct 24. Transl Cancer Res. 2023. PMID: 37969399 Free PMC article.
Impact of Multiple COVID-19 Waves on Gynaecological Cancer Services in the UK.
Oxley S, Kalra A, Sideris M, Itzkowitz N, Evans O, Atakpa EC, Brentnall AR, Dworschak N, Gaba F, Gabe R, Sundar S, Wood N, Nicum S, Taylor A, Dobbs S, McCluggage WG, Nordin A, Legood R, Kehoe S, Ghaem-Maghami S, Manchanda R. Oxley S, et al. Among authors: kehoe s. Cancers (Basel). 2023 Feb 16;15(4):1273. doi: 10.3390/cancers15041273. Cancers (Basel). 2023. PMID: 36831615 Free PMC article.
313 results